PACB
Pacific Biosciences of California Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$1.33
+0.06 ▲ +4.72%
🌙 3월 13일 7:59 PM ET (한국 3/14 08:59)
$1.30
-0.03 ▼ -2.26%
| Index | RUT | P/E | - | EPS (ttm) | -1.83 | Insider Own | 10.17% | Shs Outstand | 0.30B | Perf Week | -3.62% |
| Market Cap | 0.40B | Forward P/E | - | EPS next Y | 8.93% | Insider Trans | -2.32% | Shs Float | 0.27B | Perf Month | -27.72% |
| Enterprise Value | 0.82B | PEG | - | EPS next Q | -0.14 | Inst Own | 57.86% | Short Float | 14.08% | Perf Quarter | -43.88% |
| Income | -0.55B | P/S | 2.51 | EPS this Y | 71.99% | Inst Trans | 5.78% | Short Ratio | 5.28 | Perf Half Y | 5.56% |
| Sales | 0.16B | P/B | 75.1 | EPS next 5Y | 39.58% | ROA | -53.45% | Short Interest | 38.19M | Perf YTD | -28.88% |
| Book/sh | 0.02 | P/C | 1.44 | EPS past 3/5Y | -9.18% - | ROE | -213.45% | 52W High | -51.28% ($2.73) | Perf Year | 10.83% |
| Cash/sh | 0.93 | P/FCF | - | Sales past 3/5Y | 7.64% 15.19% | ROIC | -77.25% | 52W Low | 56.27% ($0.85) | Perf 3Y | -84.77% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -61.5% | Gross Margin | -196.47% | Volatility(W/M) | 6.41% 8.06% | Perf 5Y | -96.08% |
| Dividend TTM | - | EV/Sales | 5.15 | Sales Y/Y TTM | 3.89% | Oper. Margin | -330.95% | ATR (14) | 0.13 | Perf 10Y | -83.01% |
| Dividend Ex-Date | - | Quick Ratio | 4.47 | EPS Q/Q | 71.82% | Profit Margin | -341.47% | RSI (14) | 33.82 | Recom | 2.4 |
| Dividend Gr. 3/5Y | - | Current Ratio | 5.15 | Sales Q/Q | 13.82% | SMA20 | -13.78% ($1.54) | Beta | 2.35 | Target Price | $2.25 |
| Payout | - | Debt/Eq | 131.29 | Earnings | 2000000 | SMA50 | -29.88% ($1.9) | Rel Volume | 0.7 | Prev Close | $1.27 |
| Employees | 485 | LT Debt/Eq | 131.21 | EPS/Sales Surpr. | 9.53% 3.74% | SMA200 | -19.27% ($1.65) | Avg Volume(3M) | 7.24M | Price | $1.33 |
| IPO | 2010/10/27 | Option/Short | Yes/Yes | Trades | 8837 | Volume | 5,082,346 | Change | 4.72% |
뉴스 로딩 중...